0001209191-19-039564.txt : 20190701
0001209191-19-039564.hdr.sgml : 20190701
20190701085824
ACCESSION NUMBER: 0001209191-19-039564
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190628
FILED AS OF DATE: 20190701
DATE AS OF CHANGE: 20190701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arkowitz David
CENTRAL INDEX KEY: 0001296999
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37718
FILM NUMBER: 19931403
MAIL ADDRESS:
STREET 1: C/O FLEXION THERAPEUTICS, INC.
STREET 2: 10 MALL ROAD, SUITE 301
CITY: BURLINGTON
STATE: MA
ZIP: 01803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spring Bank Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001566373
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 522386345
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 PARKWOOD DRIVE
STREET 2: SUITE 210
CITY: HOPKINTON
STATE: MA
ZIP: 01748
BUSINESS PHONE: 508-473-5993 X119
MAIL ADDRESS:
STREET 1: 35 PARKWOOD DRIVE
STREET 2: SUITE 210
CITY: HOPKINTON
STATE: MA
ZIP: 01748
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-28
0
0001566373
Spring Bank Pharmaceuticals, Inc.
SBPH
0001296999
Arkowitz David
C/O SPRING BANK PHARMACEUTICALS, INC.
35 PARKWOOD DRIVE
HOPKINTON
MA
01748
1
0
0
0
Common Stock
2019-06-28
4
A
0
3896
0.00
A
24652
D
Pursuant to the Issuer's Non-Employee Director Compensation Policy, the shares on this Form 4 were automatically issued to the Reporting Person, who previously elected to receive shares in lieu of cash compensation for services as a director and committee member.
/s/ Lori Firmani, attorney-in-fact
2019-07-01